Elizabeth Habermann, PhD MPH Mayo Clinic
Opioid Prescribing following Surgery at Three Academic Medical - - PowerPoint PPT Presentation
Opioid Prescribing following Surgery at Three Academic Medical - - PowerPoint PPT Presentation
Opioid Prescribing following Surgery at Three Academic Medical Centers: Using Evidence to Improve Practice and Guide Quality Elizabeth Habermann, PhD MPH Mayo Clinic Learning Objective: To understand how one - size fits all
- To understand how “one-size fits all” guidelines or legislation on surgery
prescribing may not be appropriate
Learning Objective:
- In response to the opioid epidemic, a number of state and federal policymakers
either have implemented or are considering implementing guidelines or legislation to limit opioid prescribing following surgery
- However, these guidelines do not recognize variations in need by surgical procedure
- “Prescribe no more opioids than will be needed for initial tissue recovery following more
extensive surgical procedures…
- “Limit the entire prescription to 200 MME (not 200 MME/day).”
Overview:
https://mn.gov/dhs/assets/2017-opip-overview_tcm1053-320120.pdf
The Evidence:
(Ann Surg 2017;266;564-573)
- Adults undergoing 25 common elective procedures
(2013-2015):
- Institutional ACS-NSQIP data + prescription data
- Calculated Oral Morphine Equivalents (OME) and
compared to State of Minnesota draft guidelines of max 200 OME following major surgery
Methods
Procedure Groups
GENERAL SURGERY 1. Lap Cholecystectomy 2. Lap Initial Inguinal Hernia Repair 3. Initial Inguinal Hernia Repair 4. Ventral Hernia Repair GENERAL SURGICAL ONCOLOGY 5. Simple Mastectomy 6. Breast Lumpectomy 7. Ileocecectomy 8. Laparoscopic LAR 9. VATS Wedge Resection ORTHOPEDIC
- 10. Total Shoulder
- 11. Total Hip
- 12. Knee Arthroscopic Meniscectomy
- 13. Total Knee
- 14. Rotator Cuff Repair
SPINE
- 15. Lumbar Laminotomy
- 16. Lumbar Laminectomy
UROLOGY/GYNECOLOGY
- 17. Lap Hysterectomy
- 18. Vaginal Hysterectomy,
- 19. Lap Nephrectomy
- 20. Lap Prostatectomy
HEAD & NECK
- 21. Thyroid Lobectomy
- 22. Parathyroidectomy
- 23. Carotid Thromboendarterectomy
- 24. Parotid Gland Excision
- 25. Tonsillectomy
Opioid Naïve Patients
75.2% of patients (n=5,756)
20 40 60 80 100 120 140 160 180 200 200 400 600 800 1000 1200 1400
Standardized to 5mg Tabs of Oxycodone Prescribed Oral Morphine Equivalents (OME)
Procedure
OME Prescribed in Opioid Naïve Patients
80.9% of opioid naïve patients received > 200 OME (This varied by procedure)
- But how much do surgical patients use?
- Patient survey data from our institution:
- Median amounts used varied by procedure, from 0 to 400 OME
Data to be presented at the American Surgical Association in April 2018
Utilization data and patient and procedural predictors of high or low opioid consumption will inform institutional prescribing guidelines.
- Data on patient consumption and pain control is what should drive policy, not a one-size-fits all limit
The Evidence:
- Variations by surgical procedure
- Amount of opioids prescribed at discharge
- Amount of opioids consumed by surgical patients
- need for more procedure-specific policy or guidance
Health Policy Implications:
Procedure
Hydrocodone (Norco)
5 mg tablets
Codeine (Tylenol #3) Oxycodone
30 mg tablets 5 mg tablets
Tramadol
50 mg tablets
Laparoscopic Cholecystectomy 15 10 Laparoscopic Appendectomy 15 10 Inguinal/Femoral Hernia Repair (open/laparoscopic) 15 10 Open Incisional Hernia Repair 40 25 Laparoscopic Colectomy 35 25 Open Colectomy 40 25 Hysterectomy Vaginal 20 15 Laparoscopic & Robotic 30 20 Abdominal 40 25 Wide Local Excision ± Sentinel Lymph Node Biopsy 30 20 Simple Mastectomy ± Sentinel Lymph Node Biopsy 30 20 Lumpectomy ± Sentinel Lymph Node Biopsy 15 10 Breast Biopsy or Sentinel Lymph Node Biopsy 15 10
https://opioidprescribing.info/
- There is wide variation and over prescription of opioids to surgical patients
- State and federal policies have been developed to address overprescription
- But may not be appropriate for all surgical procedures
- Institutionally, we have used these data to develop specialty- and procedure-specific guidelines
- Future policy should consider these differences
- Next steps:
- Disseminate evidence to policy makers to reflect procedural and patient variation in
appropriate opioid prescriptions
- Individualized medicine and pharmacogenomics
- Continued refinement of best practices and policy